Maze Therapeutics Inc (MAZE)

Sep 30, 2025

Predicting Maze Therapeutics Inc. trend using moving averagesJuly 2025 Sector Moves & Short-Term High Return Ideas - newser.com

Sep 30, 2025

Sep 30, 2025

Detecting price anomalies in Maze Therapeutics Inc. with AIJuly 2025 Rallies & Community Supported Trade Ideas - newser.com

Sep 30, 2025

Sep 30, 2025

Goldman Sachs Group Inc. Makes New $145,000 Investment in Maze Therapeutics, Inc. $MAZE - Defense World

Sep 30, 2025

Sep 29, 2025

Maze Therapeutics (NASDAQ:MAZE) Stock Price Down 5.2%Should You Sell? - MarketBeat

Sep 29, 2025

Sep 29, 2025

What technical models suggest about Maze Therapeutics Inc.’s comebackDip Buying & Advanced Swing Trade Entry Alerts - newser.com

Sep 29, 2025

Sep 29, 2025

Developing predictive dashboards with Maze Therapeutics Inc. dataJuly 2025 PreEarnings & Weekly High Momentum Picks - newser.com

Sep 29, 2025

Sep 29, 2025

Maze Therapeutics (NASDAQ:MAZE) Price Target Raised to $37.00 at JPMorgan Chase & Co. - MarketBeat

Sep 29, 2025

Sep 28, 2025

What drives Maze Therapeutics Inc stock priceAnalyst Downgrades & High Yield Trading Growth - earlytimes.in

Sep 28, 2025

Sep 27, 2025

What analysts say about Maze Therapeutics Inc stockEarnings Beat Highlights & Outstanding Trading Tips - earlytimes.in

Sep 27, 2025

Sep 25, 2025

Maze Therapeutics (NASDAQ:MAZE) Stock Price Up 4.4%Still a Buy? - MarketBeat

Sep 25, 2025

Sep 24, 2025

Maze Therapeutics (NASDAQ:MAZE) Reaches New 52-Week HighHere's Why - MarketBeat

Sep 24, 2025

Sep 24, 2025

Maze Therapeutics, Inc. (NASDAQ:MAZE) Receives $32.67 Average PT from Analysts - Defense World

Sep 24, 2025

Sep 23, 2025

How hedge fund analytics apply to Maze Therapeutics Inc. stock2025 Institutional Moves & Weekly Top Performers Watchlists - newser.com

Sep 23, 2025

Sep 23, 2025

Maze Therapeutics, Inc. (NASDAQ:MAZE) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Sep 23, 2025

Sep 22, 2025

HC Wainwright Reaffirms Buy Rating for Maze Therapeutics (NASDAQ:MAZE) - MarketBeat

Sep 22, 2025

Sep 22, 2025

Analyzing Maze Therapeutics (NASDAQ:MAZE) and Syndax Pharmaceuticals (NASDAQ:SNDX) - Defense World

Sep 22, 2025

Sep 21, 2025

Institution Moves: What’s the fair value of Maze Therapeutics Inc. stock2025 Price Momentum & Stepwise Entry/Exit Trade Alerts - خودرو بانک

Sep 21, 2025

Sep 20, 2025

Candlestick signals on Maze Therapeutics Inc. stock todayTrade Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com

Sep 20, 2025

Sep 20, 2025

Maze Therapeutics (NASDAQ:MAZE) Director Sells $464,043.28 in Stock - MarketBeat

Sep 20, 2025

Sep 19, 2025

Maze Therapeutics Inc. stock trend outlook and recovery pathNew Guidance & Free Expert Approved Momentum Trade Ideas - newser.com

Sep 19, 2025

Sep 19, 2025

Market reaction to Maze Therapeutics Inc.’s recent newsIPO Watch & Community Driven Trade Alerts - newser.com

Sep 19, 2025

Sep 19, 2025

Will Maze Therapeutics Inc. rebound enough to break even2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - newser.com

Sep 19, 2025

Sep 19, 2025

Maze Therapeutics, Inc. (MAZE): A Bull Case Theory - Insider Monkey

Sep 19, 2025

Sep 19, 2025

Maze Therapeutics (NASDAQ:MAZE) Receives “Buy” Rating from HC Wainwright - Defense World

Sep 19, 2025

Sep 18, 2025

Can Maze Therapeutics Inc. recover in the next quarterQuarterly Profit Summary & Weekly Top Performers Watchlists - newser.com

Sep 18, 2025

Sep 18, 2025

Biotech Breakouts: 3 Stocks With Massive Upside Potential - Investing.com

Sep 18, 2025

Sep 18, 2025

Tools to monitor Maze Therapeutics Inc. recovery probability2025 Support & Resistance & Safe Entry Zone Tips - newser.com

Sep 18, 2025

Sep 18, 2025

Analyzing drawdowns of Maze Therapeutics Inc. with statistical toolsJuly 2025 Summary & Proven Capital Preservation Methods - newser.com

Sep 18, 2025

Sep 17, 2025

Biotech Breakouts: 3 Stocks With Massive Upside Potential - sharewise.com

Sep 17, 2025

Sep 17, 2025

Maze Therapeutics (NASDAQ:MAZE) Shares Gap DownHere's Why - MarketBeat

Sep 17, 2025

Sep 17, 2025

Maze Therapeutics director Scheller sells $464k in shares By Investing.com - Investing.com Australia

Sep 17, 2025

Sep 17, 2025

New Options Available for Maze Therapeutics (MAZE) - GuruFocus

Sep 17, 2025

Sep 16, 2025

Quarterly Recap: Will COOT outperform tech stocks2025 Valuation Update & Consistent Growth Stock Picks - خودرو بانک

Sep 16, 2025

Sep 16, 2025

Maze Therapeutics Director Cashes Out in Major Stock Sale! - TipRanks

Sep 16, 2025